Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Free Cash Flow (2016 - 2025)

InspireMD's Free Cash Flow history spans 16 years, with the latest figure at -$9.7 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 37.98% year-over-year to -$9.7 million; the TTM value through Dec 2025 reached -$36.8 million, down 57.99%, while the annual FY2025 figure was -$36.8 million, 57.99% down from the prior year.
  • Free Cash Flow reached -$9.7 million in Q4 2025 per NSPR's latest filing, down from -$9.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.6 million in Q2 2021 to a low of -$9.7 million in Q4 2025.
  • Average Free Cash Flow over 5 years is -$5.3 million, with a median of -$4.6 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: increased 22.35% in 2023, then plummeted 84.49% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$3.0 million in 2021, then decreased by 9.38% to -$3.3 million in 2022, then tumbled by 33.5% to -$4.4 million in 2023, then crashed by 60.77% to -$7.1 million in 2024, then crashed by 37.98% to -$9.7 million in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Free Cash Flow are -$9.7 million (Q4 2025), -$9.0 million (Q3 2025), and -$8.9 million (Q2 2025).